Changes in Gastrointestinal Hormone Responses, Insulin Sensitivity, and Beta-Cell Function Within 2 Weeks After Gastric Bypass in Non-diabetic Subjects

[1]  J. Holst,et al.  Dissociated incretin hormone response to protein versus fat ingestion in obese subjects , 2011, Diabetes, obesity & metabolism.

[2]  J. Holst.  Postprandial Insulin Secretion After Gastric Bypass Surgery , 2011, Diabetes.

[3]  A. Mari,et al.  Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes , 2011, Diabetologia.

[4]  B. Geloneze,et al.  Early Improvement in Glycemic Control After Bariatric Surgery and Its Relationships with Insulin, GLP-1, and Glucagon Secretion in Type 2 Diabetic Patients , 2011, Obesity surgery.

[5]  J. Holst,et al.  Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. , 2011, The Journal of clinical endocrinology and metabolism.

[6]  B. Kulseng,et al.  Impact of Sustained Weight Loss Achieved through Roux-en-Y Gastric Bypass or a Lifestyle Intervention on Ghrelin, Obestatin, and Ghrelin/Obestatin Ratio in Morbidly Obese Patients , 2011, Obesity surgery.

[7]  J. Rehfeld,et al.  Incretin physiology beyond glucagon‐like peptide 1 and glucose‐dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides , 2011, Acta physiologica.

[8]  S. Ikramuddin,et al.  Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. , 2011, JPEN. Journal of parenteral and enteral nutrition.

[9]  L. Czupryniak,et al.  Plasma glucose after stomach or jejunum glucose infusion in Roux-en-Y gastric bypass patients--a possible implication for early satiety mechanism. , 2011, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[10]  K. Rother,et al.  Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. , 2010, The Journal of clinical endocrinology and metabolism.

[11]  N. Abumrad,et al.  The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity After Roux-en-Y Gastric Bypass Surgery , 2010, Diabetes Care.

[12]  J. Holst,et al.  Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses. , 2010, Metabolism: clinical and experimental.

[13]  C. Earthman,et al.  Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. , 2010, Journal of the American Dietetic Association.

[14]  P. Schauer,et al.  Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes , 2010, International Journal of Obesity.

[15]  J. Holst,et al.  Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion , 2009, Diabetes Care.

[16]  M. Schambelan,et al.  Improvement in Peripheral Glucose Uptake After Gastric Bypass Surgery Is Observed Only After Substantial Weight Loss Has Occurred and Correlates with the Magnitude of Weight Lost , 2009, Journal of Gastrointestinal Surgery.

[17]  R. Bisschops,et al.  Pathophysiology, diagnosis and management of postoperative dumping syndrome , 2009, Nature Reviews Gastroenterology &Hepatology.

[18]  C. Mottin,et al.  Obese Patients with Type 2 Diabetes Submitted to Banded Gastric Bypass: Greater Incidence of Dumping Syndrome , 2009, Obesity surgery.

[19]  M. Jensen,et al.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. , 2009, The American journal of medicine.

[20]  Y. Seto,et al.  Effects of reconstruction methods on a patient’s quality of life after a proximal gastrectomy: subjective symptoms evaluation using questionnaire survey , 2009, Langenbeck's Archives of Surgery.

[21]  M. Deitel.  The Change in the Dumping Syndrome Concept , 2008, Obesity surgery.

[22]  C. Deacon,et al.  Incretin and islet hormonal responses to fat and protein ingestion in healthy men. , 2008, American journal of physiology. Endocrinology and metabolism.

[23]  J. Teixeira,et al.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. , 2008, The Journal of clinical endocrinology and metabolism.

[24]  A. Lacy,et al.  Circulating Peptide YY, Weight Loss, and Glucose Homeostasis After Gastric Bypass Surgery in Morbidly Obese Subjects , 2008, Annals of surgery.

[25]  M. Suter,et al.  Effects of Gastric Bypass and Gastric Banding on Glucose Kinetics and Gut Hormone Release , 2008, Obesity.

[26]  S. Bloom,et al.  Gut Hormones as Mediators of Appetite and Weight Loss After Roux-en-Y Gastric Bypass , 2007, Annals of surgery.

[27]  J. Holst,et al.  Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[28]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[29]  J. Holst,et al.  The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas , 2007, Diabetologia.

[30]  K. Parhofer.  [Glucagon-like peptide 1 (GLP-1)]. , 2007, MMW Fortschritte der Medizin.

[31]  M. Sundbom,et al.  Early Changes in Ghrelin following Roux-en-Y Gastric Bypass: Influence of Vagal Nerve Functionality? , 2007, Obesity surgery.

[32]  L. Phillips,et al.  Increases in Adiponectin Predict Improved Liver, but Not Peripheral, Insulin Sensitivity in Severely Obese Women During Weight Loss , 2007, Diabetes.

[33]  S. Bloom,et al.  Gut hormones and the regulation of energy homeostasis , 2006, Nature.

[34]  M. Bessler,et al.  Differential Effects of Gastric Bypass and Banding on Circulating Gut Hormone and Leptin Levels , 2006, Obesity.

[35]  D. Cummings.  Ghrelin and the short- and long-term regulation of appetite and body weight , 2006, Physiology & Behavior.

[36]  Josep Vidal,et al.  Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. , 2006, The Journal of clinical endocrinology and metabolism.

[37]  S. Bloom,et al.  Progressive rise in gut hormone levels after Roux‐en‐Y gastric bypass suggests gut adaptation and explains altered satiety , 2006, The British journal of surgery.

[38]  R. Batterham,et al.  Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters , 2006, Annals of surgery.

[39]  J. Holst,et al.  Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. , 2006, Gastroenterology.

[40]  M. Bessler,et al.  Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. , 2005, The Journal of clinical endocrinology and metabolism.

[41]  M. Gagner,et al.  The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism , 2004, Annals of surgery.

[42]  D. Cummings,et al.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.

[43]  L. Kuller,et al.  Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus , 2003, Annals of surgery.

[44]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[45]  L. Flancbaum.  Mechanisms of weight loss after bariatric surgery. , 2003, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[46]  J. Holst,et al.  Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. , 2003, The Journal of clinical endocrinology and metabolism.

[47]  E. Dellinger,et al.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.

[48]  M. Papotti,et al.  Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[49]  J. Rehfeld,et al.  The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. , 2001, The Journal of clinical endocrinology and metabolism.

[50]  T. Moran,et al.  Cholecystokinin and satiety: current perspectives. , 2000, Nutrition.

[51]  Xia Li,et al.  Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[52]  J. Holst,et al.  Structure, measurement, and secretion of human glucagon-like peptide-2 , 2000, Peptides.

[53]  O. Ljungqvist,et al.  Insulin resistance: a marker of surgical stress. , 1999, Current opinion in clinical nutrition and metabolic care.

[54]  J. Rehfeld.  Accurate measurement of cholecystokinin in plasma. , 1998, Clinical chemistry.

[55]  A. Niijima,et al.  The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein. , 1996, Journal of the autonomic nervous system.

[56]  W. Pories,et al.  Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult‐Onset Diabetes Mellitus , 1995, Annals of surgery.

[57]  B. Göke,et al.  Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. , 1995, Digestion.

[58]  J. Holst,et al.  Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans , 1994, Diabetes.

[59]  V. Marks,et al.  Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. , 1993, The Journal of endocrinology.

[60]  J. Holst,et al.  Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. , 1991, The Journal of clinical investigation.

[61]  D. Martin,et al.  Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. , 1990, Annals of surgery.

[62]  J. Olefsky,et al.  Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. , 1985, The Journal of clinical endocrinology and metabolism.

[63]  E. Schrumpf,et al.  The effect of gastric bypass operation on glucose tolerance in obesity. , 1985, Scandinavian journal of gastroenterology. Supplement.

[64]  J. Holst,et al.  The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera , 1984, Regulatory Peptides.

[65]  J. Holst,et al.  Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. , 1983, The Journal of clinical endocrinology and metabolism.

[66]  J. Holst,et al.  On the accuracy of radioimmunological determination of somatostatin in plasma , 1982, Regulatory Peptides.

[67]  E. Schrumpf,et al.  Gastrin secretion before and after gastric bypass surgery for morbid obesity. , 1981, Scandinavian journal of gastroenterology.

[68]  Larry J. Miller.  Gut Hormones , 1978, Proceedings of the Nutrition Society.

[69]  R. Holman,et al.  INSULIN RATHER THAN GLUCOSE HOMŒOSTASIS IN THE PATHOPHYSIOLOGY OF DIABETES , 1976, The Lancet.

[70]  J. Rehfeld,et al.  PANCREATIC-POLYPEPTIDE RESPONSE TO FOOD IN DUODENAL-ULCER PATIENTS BEFORE AND AFTER VAGOTOMY , 1976, The Lancet.

[71]  Rehfeld Jf.  Gastrins in serum. A review of gastrin radioimmunoanalysis and the discovery of gastrin heterogeneity in serum. , 1973 .

[72]  J. Rehfeld.  Gastrins in serum. A review of gastrin radioimmunoanalysis and the discovery of gastrin heterogeneity in serum. , 1973, Scandinavian journal of gastroenterology.

[73]  J. Rehfeld,et al.  Production and evaluation of antibodies for the radioimmunoassay of gastrin. , 1972, Scandinavian journal of clinical and laboratory investigation.